MONTREAL, Dec. 27, 2013 /CNW Telbec/ - Aptilon Corporation ("Aptilon" or the "Company") (NEX: APZ.H), today
announced that it had filed its proxy information circular for the
fiscal periods ended December 31, 2011 and 2012 and that it had filed
its financial reports for the year ended December 31, 2012 and the
quarters ended March 31, June 30 and September 30, 2013 on SEDAR.
Filing of financial reports
The Company has filed on SEDAR its audited financial statements and
Management Discussion and Analysis report ("MD&A") for the year ended
December 31, 2012 as well as its unaudited financial statements and
MD&A for the periods ended March 31, 2013, June 30, 2013 and
September 30, 2013. Complete financial statements and MD&A are
available on SEDAR at www.sedar.com.
With these filings, the Company is now up-to-date with all of its filing
requirements. The Company will now undertake the process of lifting
the cease trade order on its securities.
Filing of proxy information circular and annual meeting
The proxy information circular for the fiscal periods ended December 31,
2011 and 2012 has been produced and sent for printing and will be filed
on SEDAR and mailed on December 30, 2013. As announced in a previous
press release, the Company's annual meeting will be held on Friday,
January 24, 2014.
About Aptilon Corporation
Aptilon enables pharmaceutical, pharmaceutical marketing companies,
digital advertising agencies and medical device companies to
effectively reach, message, connect and interact with US physicians and
healthcare professionals via multiple access channels. Its innovative
service offerings provide targeted impressions and interactions through
permission-based email, targeted on-line ad-serving, and mobile app
advertising channels. Top pharmaceutical companies, agencies and
respected healthcare organizations have adopted Aptilon's solutions to
target, engage and interact with leading healthcare practitioners. For
more information, visit www.dmdconnects.com .
This news release contains forward-looking information. These statements
relate to future events or future performance and reflect management's
current expectations and assumptions. Such forward-looking statements
reflect management's current beliefs and are based on information
currently available to management of Aptilon. A number of factors could
cause actual events, performance or results to differ materially from
the events performance and results discussed in the forward-looking
statements. These forward-looking statements are made as of the date
hereof and Aptilon does not assume any obligation to update or revise
them to reflect new events or circumstances.
Neither NEX, the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this
SOURCE: Aptilon Holdings
For further information:
514-422-0777 ext. 229